Your hub for company news and information

Posted on November 23, 202111/23/21

Australian AI Company Artrya Announces Major UK Commercialisation Partnership With EVERSANA

Read More

Recent Press Releases

Posted on November 8, 202111/8/21

Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership

Posted on November 4, 202111/4/21

Membership in European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Posted on October 20, 202110/20/21

EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization

Posted on October 15, 202110/15/21

EVERSANA Acquires Protean; strengthens operational strategy and excellence in market access, channel and patient services

Posted on October 12, 202110/12/21

MINDPAX and EVERSANA announce U.S. commercialization partnership to launch revolutionary digital therapeutic solution for bipolar disorders

Posted on October 11, 202110/11/21

EVERSANA™ named a Great Place to Work for third consecutive year in U.S.; earns valuable recognition in Canada, China and India

Posted on October 5, 202110/5/21

EVERSANA joins phactMI Corporate Partner Program, helping to shape the future of medical information services

Posted on September 27, 20219/27/21

EVERSANA Named PM360 Trailblazer Award Winner In 2021 For Both Data & Analytics Innovation and Engaging Sales Collateral

Posted on September 23, 20219/23/21

Digital Therapeutics Alliance Announces New Resource Partner Program to Accelerate Access and Impact of Digital Therapeutics for Patients Worldwide

Posted on September 9, 20219/9/21

CEO Jim Lang Honored With PharmaVOICE Top 100 Commanders & Chiefs Award